Occult Cancer in Patients with Venous Thromboembolism: which Patients, which Cancers

Summary

We have previously demonstrated that patients with idiopathic venous thromboembolism (VTE) have a higher frequency of underlying cancer. Now we present a retrospective analysis of our 5-year experience with a series of 674 consecutive otherwise healthy patients, and a more restricted battery of diagnostic tests. Occult cancer was found in 15 patients during admission. The diagnostic tools which led to suspect occult cancer were: abdominal CT-scan (4 patients); high carcinoembryonic levels (2 patients); and high prostate-specific antigen levels (9 patients). Eight further patients were diagnosed of cancer after discharge. Cancer was more commonly found in patients with idiopathic VTE: 13/105 patients (12%) versus 10/569 patients (2%); p <0.01; 0. R.: 7.9 (95% Cl: 3.14-20.09).

During the same period of time we diagnosed VTE in 147 patients with previously known cancer. When overall considered, VTE was the first sign of malignancy in most patients with prostatic and pancreatic carcinoma. On the contrary, most patients with breast, lung, uterine and brain cancers developed VTE as a terminal event of the disease. At variance with VTE patients and previously known cancer, most patients with occult malignancy were at an early stage. Further studies are needed to confirm whether patients with idiopathic VTE could benefit from screening for occult cancer. Meanwhile, our findings may serve as guidelines for physicians in this field.

• References

• 1 Gore JM, Appelbaum JS, Greene HL, Dexter L, Dalen JE. Occult cancer in patients with acute pulmonary embolism. Ann Intern Med 1982; 96: 556-560
• 2 Aderka D, Brown A, Zelikovski A, Pinkhas J. Idiopathic deep vein thrombosis in an apparently healthy patient as a premonitory sign of occult cancer. Cancer 1986; 57: 1846-1849
• 3 Goldberg RJ, Seneff M, Gore JM, Anderson FA, Greene HL, Wheeler B, Dalen JE. Occult malignant neoplasm in patients with deep venous thrombosis. Arch Intern Med 1987; 147: 251-253
• 4 Griffin MR, Stanson AW, Brown ML, Hauser MF, O’Fallon WM, Anderson HM, Kazmier FJ, Melton LJ. Deep venous thrombosis and pulmonary embolism. Risk of subsequent neoplasms. Arch Intern Med 1987; 147: 1907-1911
• 5 Monreal M, Salvador R, Soriano V, Sabria M. Cancer and deep venous thrombosis. Arch Intern Med 1988; 148: 485 (letter to the Editor)
• 6 Monreal M, Lafoz E, Casals A, Inaraja L, Montserrat E, Callejas JM, Martorell A. Occult cancer in patients with deep venous thrombosis. A systematic approach. Cancer 1991; 67: 541-545
• 7 Prandoni P, Lensing AWA, Biiller HR, Cogo A, Prins MH, Cattelan AM, Cuppini S, Noventa F, ten CateJW. JW. Deep-vein thrombosis and the incidence of subsequent symptomatic cancer. N Engl J Med 1992; 327: 1128-1133
• 8 Monreal M, Casals A, Boix J, Olazabal A, Montserrat E, Ribas-Mundo M. Occult cancer in patients with acute pulmonary embolism. A prospective study. Chest 1993; 103: 816-819
• 9 Prins MH, Lensing AWA, Hirsh J. Idiopathic deep venous thrombosis. Is a search for malignant disease justified?. Arch Intern Med 1994; 154: 1310-1312
• 10 Nordstrom M, Lindblad B, Anderson H, Bergqvist D, Kjellström T. Deep venous thrombosis and occult malignancy: an epidemiological study. Brit Med J 1994; 308: 891-894
• 11 O’Connor NTJ, Cederholm-Williams SA, Fletcher EW, Allington M, Sharp AA. Significance of idiopathic deep venous thrombosis. Postgrad Med J 1984; 60: 275-277
• 12 Ahmed Z, Mohyuddin Z. Deep vein thrombosis as a predictor of cancer. Angiology 1966; 47: 261-265
• 13 UICC International Union Against Cancer. TNM Classification of malignant tumours. Hermanek P, Sobin LH. eds. Berlin, Heidelberg, New York: Springer; 1987
• 14 Mettlin C, Jones G, Averette H, Gusberg SB, Murphy GP. Defining and updating the American Cancer Society guidelines for the cancer-related checkup: prostate and endometrial cancers. CA Cancer J Clin 1993; 43: 42-46
• 15 Woolf SH. Screening for prostate cancer with prostate-specific antigen. An examination of the evidence. N Engl J Med 1995; 333: 1401-1405
• 16 St JohnD JB, Young GO, Alexyeff MA, Deacon MC, Cuthbertson AM, Macrae FA, Penfold CB. Evaluation of new occult blood tests for detection of colorectal neoplasia. Gastroenterology 1993; 104: 1661-1668
• 17 Allison JE, Feldman R, Tekawa IS. Hemoccult screening in detecting colorectal neoplasm: sensitivity, specificity and predictive value. Ann· Intern Med 1990; 112: 328-333
• 18 Selby JV, Friedman GD, Quesenberry CP, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992; 326: 653-657
• 19 Muller AD, Sonnenberg A. Protection by endoscopy against death from colorectal cancer: a case-control study among veterans. Arch Intern Med 1995; 108: 402-408
• 20 Bhattacharya I, Sack EM. Screening colonoscopy: the cost of common sense. Lancet 1996; 347: 1744-1745